FDA approves expanded MRI labeling for Abbott neurostim : co

FDA approves expanded MRI labeling for Abbott neurostim

Abbott (NYSE: ABT) announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system.

Related Keywords

West Virginia , United States , Pedro Malha , Nerve Centers Of The Virginias , Timothy Deer , Nerve Centers ,

© 2024 Vimarsana